IQVIA Holdings Inc. (0JDM.L)
| Previous Close | 228.87 |
| Open | 230.91 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 228.15 - 234.14 |
| 52 Week Range | 166.94 - 261.42 |
| Volume | |
| Avg. Volume | 1,650 |
| Market Cap | 463.477M |
| Beta (5Y Monthly) | 1.53 |
| PE Ratio (TTM) | 0.42 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
RESEARCH TRIANGLE PARK, N.C., May 09, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m. ET (9:20 a.m. local PT).
- Business Wire
IQVIA Reports First-Quarter 2024 Results
RESEARCH TRIANGLE PARK, N.C., May 02, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.
- Business Wire
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
RESEARCH TRIANGLE PARK, N.C., April 23, 2024--IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.
